ALDA Pharmaceuticals Corp.
TSX VENTURE : APH
OTC Bulletin Board : APCSF

ALDA Pharmaceuticals Corp.

April 21, 2009 11:52 ET

ALDA Launching New Products at O.D.A. Meeting, April 30, 2009

VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 21, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") announces that the Company's representatives will be attending the 142nd Annual Spring Meeting ("ASM") of the Ontario Dental Association ("ODA") commencing on April 30, 2009. This meeting is the largest dental conference held in Canada and is taking place at the Metro Toronto Convention Centre. Joining over 275 other exhibitors at the ASM, ALDA will be presenting its new product line at Booth 241 to over 10,000 dentists and 25,000 dental staff.

The product line to be presented includes:

- T36® Disinfectant

- T36® Disinfectant Wipes

- T36® Antiseptic Hand Sanitizer Gel

- T36® Antiseptic Hand Sanitizer Wipes

- T36® Disinfectant Cleaner CONCENTRATE

Additional products that will be introduced after the meeting include T36® Antiseptic Hand Sanitizer Liquid and T36 Disinfex™ Disinfectant Cleaner.

Dr. Terrance Owen, President & CEO, states, "We have been working towards a coordinated launch of all of ALDA's products at this show for some time. All the pieces have come together for us to undertake a major promotion of the Company products to the dental industry at this gathering. We want to move forward to other markets as soon as possible thereafter by bolstering our sales and marketing expertise and seeking out new distributors that can tackle all the other markets we see for the T36® technology."

Delegates to the ASM are invited to visit ALDA at Booth 241 to meet with company representatives and receive samples of the new products.

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T36® technology. The company trades on the TSX Venture Exchange under the symbol APH and in the U.S. on the OTCBB under the symbol APCSF.

Terrance G. Owen, Ph.D., MBA, President & CEO

ALDA Pharmaceuticals Corp.

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as "outlook", "will", "could", "would", "might", "remains", "to be", "plans", "believes", "may", "expects", "intends", "anticipates", "estimate", "future", "plan", "positioned", "potential", "project", "remain", "scheduled", "set to", "subject to", "upcoming", and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Contact Information